We use CREATION Pinpoint® to produce up-to-date insights on current HCP perspectives to inform advisory board; identify shortlist of 10 most relevant HCP DOLs for engagement in the advisory board; develop deep profile of each, to inform outreach and advisory board content.
Our insights inform ad board vision. We select priority DOLs to invite; identify key themes in HCP views, aligned with your goals and position.
We collaborate with your colleagues to identify best approach for inviting each DOL.
Once contracted, schedule and facilitate pre-ad board video calls. Develop materials and script for call; conduct interview with DOL; record, transcribe and analyse learnings from DOL calls.
Using learnings from research, workshop and DOL interviews, develop agenda and content materials for ad board. Collaborate with your team on refining agenda and content.
Facilitate a lively, creative ad board session in which DOLs will share, ideate, provide individual insights and reach a vision for future collaboration around themes aligned with their passions and your goals.
The session will be designed to serve the DOLs well in reaching a shared vision that they want to be part of. CREATION.co will usually provide two consultants to facilitate the session. After the ad board, provide a report on learnings and recommendations for next steps.
Our client, a major pharmaceutical company in oncology, was concerned that certain patient populations were not gaining access to the treatment they needed.
It was clear that oncologists had a role to play in driving change, but the company did not know how best to talk about change in a way that would be meaningful to physicians.
CREATION.co identified the world’s most impactful HCP Digital Opinion Leaders in the field, and developed deep profiles to identify the DOLs’ key concerns and passions.
Insights from the physician profiles were used to invite DOLs to take part in a digital advisory board and to shape the agenda for the meeting.
During the advisory board, highlights from CREATION.co’s research were shared with the DOLs who responded by confirming what inspires them to engage online.
Through the passionate conversation with oncologists, a theme emerged about how to engage the underserved patient population.
Thanks to learnings from the advisory board, the oncologists came together to launch a movement for greater awareness of underserved patients.
They continued to collaborate with our client through several follow-up meetings and online engagements as the movement gained momentum organically among HCPs.
18.07.2024 | Article
Find out how social media insights can support your plans and save you money.
By Katie Kennedy
24.03.2025 | Article
Meet Beverly Tchang, MD, who ranks among the top 10 HCPs worldwide discussing obesity.
By Jessica Fernandes
07.03.2025 | Article
CREATION.co’s top resources to help you navigate DOLs effectively.
By Dionne Anane
At CREATION.co, we’ve led the way in using data science to identify and profile healthcare professional Digital Opinion Leaders since we first introduced the concept in 2012.
Deciding how to identify, profile and engage DOLs is a process as unique as your own goals. So we work with you to define what’s most important in your particular DOL identification and profiling exercise.
Below is an illustration of 10 of our metrics to identify your DOLs.
10 ways to identify DOLs
To learn more visit our Digital Opinion Leader Mapping page
We have been helping pharmaceutical companies with their HCP engagement strategies for the past 20 years. Based on our experience and expertise, here are our top 3 ideas on how to best engage with your HCP Digital Opinion Leaders:
For the rest of our list, check out our HCP engagement strategies article.
Once you have identified your Digital Opinion Leaders, you need to consider how to engage effectively with them. However, before you start thinking about identifying DOLs, you need to put this into context with your long-term goals and think about what would make a Digital Opinion Leader for you. You need to consider:
If you start by answering these, and other strategic DOL questions, you will have a much clearer picture of what a perfect DOL would look like for your business.
Remember, there is no single set of metrics that defines DOL impact. Individual pharma companies should design goals that reflect outcomes aligned with their business objectives. As well as ensuring those objectives also align with the goals of the DOL and, in some cases, the patient community.
At CREATION.co, we spend time ensuring those objectives have been discussed and with a pre-qualified database of nearly 3 million global HCP social media profiles, we can adjust our metrics to ensure the DOLs we identify are the right ones to support your goals.
DOLs suitable for marketing or commercial teams might look different to those suitable for the medical teams. CREATION.co have therefore identified a subset of Digital Opinion Leaders – Digital Scientific Leaders (DSLs). DSLs are HCPs who possess all the qualities of a DOL but have a specific focus and influence in the scientific conversation within the therapy area.
DSLs are driving the discussion around latest study and trial data, testing and diagnosis, and mechanism of action of treatments. In other words, they have a natural inclination to lead and shape the scientific dialogue amongst their peers online. They usually have higher scientific credentials and use their media for peer learning, education, and collaboration.
To learn more, read our article about Medical Affairs: best practice for identifying online HCP thought leaders
DOLs are already regulated, in the sense that their behaviour as professionals is governed by their respective professional bodies. In the UK, for example, the General Medical Council (GMC), which governs medical doctors, has provided guidance for doctors on their use of social media since 2013. While controversial among some doctors, the guidance forbids doctors from anonymity on social media.
Furthermore, and relevant to the role of DOLs, the GMC guidance requires doctors to declare any commercial or financial interests in pharmaceutical companies: “When you post material online, you should be open about any conflict of interest and declare any financial or commercial interests in healthcare organisations or pharmaceutical and biomedical companies.”
16.04.2025 | Article
Showcasing our new tool HCP Voice dashboard that tracks the online voice of HCPs online.
By Daniel Ghinn
16.04.2025 | Webinars
Exploring how the online voice of HCPs captured through CREATION.co’s innovative platforms
01.04.2025 | Webinars
Exploring how insights from HCPs on social media can inform and strengthen your drug launch.
24.03.2025 | Article
Meet Beverly Tchang, MD, who ranks among the top 10 HCPs worldwide discussing obesity.
By Jessica Fernandes
07.03.2025 | Article
CREATION.co’s top resources to help you navigate DOLs effectively.
By Dionne Anane
03.03.2025 | Article
Setting things straight about HCP Digital Opinion Leaders
By Anni Neumann